Effects of platelet activating factor on the bronchial musculature and vasculature in dogs
Misawa, M.; Takata, T.
Nihon Kyobu Shikkan Gakkai Zasshi 26(7): 737-744
1988
ISSN/ISBN: 0301-1542 PMID: 3241511 Document Number: 325398
Document emailed within 1 workday
Related Documents
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Fraj Lázaro, J.; Hinojosa Macías, M.; Puyana Ruiz, J. 1991: Platelet activating factor in the physiopathology of bronchial asthma Medicina Clinica 96(1): 30-34
Tsukioka, K.; Matsuzaki, M.; Nakamata, M.; Kayahara, H.; Nakagawa, T. 1996: Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma Journal of Investigational Allergology and Clinical Immunology 6(1): 22-29
Takashima, M.; Yasuda, K.; Umesaki, K.; Nakajima, T.; Sawaragi, I. 1994: Effects of estrogen and progestin on platelet-activating factor acetylhydrolase Nihon Sanka Fujinka Gakkai Zasshi 46(6): 481-488
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Toth, P.D.; Mikulaschek, A.W. 1986: Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat Circulatory Shock 20(3): 193-203
Hofmann, B.; Meisgeier, U.; Kertscher, P.; Ostermann, G. 1988: Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat Biomedica Biochimica Acta 47(10-11): S161-S164
Handley, D.A.; Van Valen, R.G.; Melden, M.K.; Houlihan, W.J.; Saunders, R.N. 1988: Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412 Journal of Pharmacology and Experimental Therapeutics 247(2): 617-623
Jiang, W.; Wang, Y.-s.; Cong, Q.; Li, M.-j.; Ye, B.; Xu, C.-j. 2011: Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro Zhonghua Fu Chan Ke Za Zhi 46(12): 931-935
Handley, D.A.; Van Valen, R.G.; Melden, M.K.; Saunders, R.N. 1984: Evaluation of dose and route effects of platelet activating factor-induced extravasation in the guinea pig Thrombosis and Haemostasis 52(1): 34-36
Fu, Y.; Hu, Y.M. 1999: Prophylactic effects of tetramethyl pyrazine on mice with endotoxemia and its relationship with platelet-activating factor Zhongguo Yao Li Xue Bao 20(6): 529-532
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320
Rocha, F.A.; Jancar, S.; Fraga, C.A.; Timo-Iaria, C.; De Brum-Fernandes, A.J. 1993: Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry Journal of Rheumatology 20(8): 1374-1377
Oztürk, H.; Oztürk, H.; Dokucu, A.I.; Otcu, S. 2006: Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats Acta Gastro-Enterologica Belgica 69(2): 197-202
Hahn, H.L.; Purnama, I.; Lang, M.; Sannwald, U. 1986: Effects of platelet activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in live ferrets European Journal of Respiratory Diseases. Suppl 146: 277-284
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
O'Donnell, S.R.; Erjefält, I.; Persson, C.G. 1990: Early and late tracheobronchial plasma exudation by platelet-activating factor administered to the airway mucosal surface in guinea pigs: effects of WEB 2086 and enprofylline Journal of Pharmacology and Experimental Therapeutics 254(1): 65-70
Farr, R.S.; Wardlow, M.L.; Cox, C.P.; Meng, K.E.; Greene, D.E. 1983: Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor Federation Proceedings 42(14): 3120-3122